Pacira Biosciences Inc
NASDAQ:PCRX

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
NASDAQ:PCRX
Watchlist
Price: 29.69 USD -2.08% Market Closed
Updated: May 28, 2024

Revenue Breakdown

Breakdown by Geography
Pacira Biosciences Inc

Not Available

Breakdown by Segments
Pacira Biosciences Inc

Total Revenue: 675m USD
100%
Net Product Sales: 672.2m USD
99.6%
Exparel: 538.1m USD
79.7%
Zilretta: 111.1m USD
16.5%
Iovera°: 19.7m USD
2.9%
Bupivacaine Liposome Injectable Suspension: 3.3m USD
0.5%
Royalty Revenue: 2.7m USD
0.4%
Show More
Show Less

See Also

Discover More